Main menu button

Equity Research Enrad, Q2 2025: Investments and growth according to plan

2 Sep 2025

Enrad AB’s net sales of SEK 15.2 million in Q2 2025 fell short of our estimate of SEK 16.2 million by about 6%. Compared with Q2 2024, sales grew by 21%. Expensed investments reduced profitability but will yield results further ahead. 

Expensed investments are building a solid foundation for the future

Enrad AB (“Enrad” or the “Company”) reported net sales of approximately SEK 15.2 million in Q2 2025, which was slightly below our estimate of SEK 16.2 million.

The gross margin of 50% came in almost in line with our estimate of 52%. However, higher-than-expected operating expenses contributed to EBIT for Q2 2025 landing at minus SEK 3.4 million, compared with our estimate of SEK 1.6 million. The elevated costs are attributable to investments that are expensed rather than capitalized, which naturally affect results already from the EBITDA level. Product development, product management, and the launch of the Dutch subsidiary are examples of investments that impacted results during the first half of 2025 but are expected in the long run to drive strong growth and sustainable profitability. Expensed investments can be expected to continue showing up in the figures, which may lead to fluctuating margins for some time ahead. The Company’s cash position amounted to approximately SEK 21.2 million as of June 30, 2025, down from SEK 37.3 million at the end of Q1 2025. Cash flow during Q2 2025 was thus about minus SEK 16.1 million.

In the Q2 2025 report, CEO Andreas Bäckäng noted that the order book is fully booked for Q3 2025, while work is progressing on replenishing the order book for Q4 2025. At the same time, the hope is that the Company may receive its first order in the Netherlands already in Q4 2025, following the major initiative launched in spring 2025 through the subsidiary Enrad B.V. As noted previously, however, lead times in the industry are long, which means that sales processes can take time.

We lower our estimates for Enrad’s net sales for 2025 slightly, from the previous SEK 67.3 million to SEK 64.3 million. For 2026 and 2027, estimates remain largely unchanged. We assume a gross margin of 52% for 2025–2028, which is then expected to decline from 50% in 2029 to 45% during 2034–2037. At the same time, we expect, as mentioned, fluctuating EBITDA and EBIT margins going forward, which we believe will be most evident during 2025 and 2026.


Disclaimer

Carlsquare AB. www.carlsquare.se. hereinafter referred to as Carlsquare. carries out activities within corporate finance and equity research and publishes. among other things. information on companies. including analyses. The information is based on sources that Carlsquare believes to be reliable. However. Carlsquare cannot guarantee the accuracy of the information. Nothing contained in the analysis should be construed as a recommendation or solicitation to invest in any financial instrument. option or the like. Opinions and conclusions expressed in the analysis are intended only for the recipient.

The content may not be copied. reproduced. or distributed to third parties without the written consent of Carlsquare. Carlsquare shall not be liable for any direct or indirect damage resulting from decisions taken based on the information contained in this analysis. Investments in financial instruments offer opportunities for capital appreciation and profits. All such investments also involve risks. Risks vary between different types of financial instruments and combinations thereof. Past performance should not be taken as an indication of future results.

The analysis is not directed at. and may not be distributed to. U.S. persons (as that term is defined in Regulation S under the U.S. Securities Act of 1933. as amended (the “Securities Act”)). The analysis is also not directed at any natural or legal person in any jurisdiction where the distribution of the analysis to such persons would constitute or risk a violation of any Swedish or foreign law or constitution.

The analysis is so-called Commissioned Research. where the analyzed company has signed an agreement with Carlsquare about the analysis coverage. The analyses are published on an ongoing basis during the contract period and for the usual fixed fee.

Carlsquare may or may not have a financial interest in what is the subject of this analysis. Carlsquare is committed to ensuring objectivity and independence and has established procedures for dealing with conflicts of interest.

The analysts Christopher Solbakke and Bertil Nilsson do not own and may not own shares in the company analysed.

Equity Research Enrad, Q2 2025: Investments and growth according to plan